• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX

AMPLIA THERAPEUTICS LIMITED - Charts / Financials

5.88% ! 16.0¢
Market Cap $82.09M  !
Healthcare Biotechnology
Add to My Watchlist

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 03/09/2025 (20 minute delay) ?
Day
Open 16.5¢   Day High 16.8¢   Day Low 16.0¢
Daily Volume 678670
Bids   Sellers
Number Price Volume   Number Price Volume
18 16.0¢ 1383859   1 16.5¢ 12242

Directors & Senior Management

Dr. Christopher John Burns Chief Executive Officer, Managing Director, Director
Mr. Hamish George Chief Financial Officer
Dr. Mark Devlin Chief Scientific Officer
Dr. Jason Lickliter Chief Medical Officer
Mr. Andrew John Cooke Company Secretary
Mr. Warwick Bonner Tong Non-Executive Independent Chairman of the Board
Mrs. Jane Bell Non-Executive Independent Director
Dr. Robert Peach Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
16.0¢ 		Change
-0.010(5.88%) 		Mkt cap ! $82.09M
Open High Low Value Volume
16.5¢ 16.8¢ 16.0¢ $110.3K 678.6K

Buyers (Bids)

No. Vol. Price($)
18 1383859 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 12242 1
View Market Depth
Last trade - 16.10pm 03/09/2025 (20 minute delay) ?
Last
16.3¢ 		  Change
-0.010 ( 2.99 %)
Open High Low Volume
16.5¢ 17.0¢ 16.0¢ 717418
Last updated 15.59pm 03/09/2025 ?

Top Stories

ABX Group joins top gainers board as ANSTO REE testwork prompts conviction

ABX Group has seen shares pop no less than +107% after Australia's nuclear regulator ANTSO confirmed "high extractions of heavy rare earths."
Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion? In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.
AGC delivers strong near-surface gold hits at Achilles AGC chief Diemar unpacks Australian Gold and Copper's outstanding near-surface gold and silver results at its Achilles discovery.
Market Close: ASX at 3-week lows, but Wall Street futures green Weds arvo Good Afternoon and welcome to HotCopper’s Market Close for Wednesday, I’m Jon Davidson. The market hit three week lows this week as Wall Street proves to be a wet blanket kicking off September; not helping matters, hotter than expected Aussie GDP showing a resilien...
Lithium plays are getting into gold. But this uranium stock's getting into REEs, antimony Energy nanocap Terra Uranium has jumped nearly +14% in afternoon trades to nearly 7cps, which brings its one-month gains to +120%.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.